Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7658)
All Articles published online
|
Publishing Process of This Article
|
Apr 27, 2014 (publication date) through Apr 3, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Vergani L. Lipid lowering effects of iodothyronines: |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v6/i4/169.htm |
| Number | Citing Articles |
| 1 |
Ilaria Demori, Adriana Voci, Elena Grasselli. The Molecular Nutrition of Fats. 2019; : 365 doi: 10.1016/B978-0-12-811297-7.00028-7
|
| 2 |
Liliana F. Iannucci, Federica Cioffi, Rosalba Senese, Fernando Goglia, Antonia Lanni, Paul M. Yen, Rohit A. Sinha. Metabolomic analysis shows differential hepatic effects of T2 and T3 in rats after short-term feeding with high fat diet. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-02205-1
|
| 3 |
Elena Grasselli, Laura Canesi, Piero Portincasa, Adriana Voci, Laura Vergani, Ilaria Demori. Models of non-Alcoholic Fatty Liver Disease and Potential Translational Value: the Effects of 3,5-L-diiodothyronine. Annals of Hepatology 2017; 16(5): 707 doi: 10.5604/01.3001.0010.2713
|
| 4 |
Giulia Vecchione, Elena Grasselli, Federica Cioffi, Francesca Baldini, Paulo J. Oliveira, Vilma A. Sardão, Katia Cortese, Antonia Lanni, Adriana Voci, Piero Portincasa, Laura Vergani. The Nutraceutic Silybin Counteracts Excess Lipid Accumulation and Ongoing Oxidative Stress in an In Vitro Model of Non-Alcoholic Fatty Liver Disease Progression. Frontiers in Nutrition 2017; 4 doi: 10.3389/fnut.2017.00042
|
| 5 |
Amedeo Lonardo. Resmetirom: Finally, the Light at the End of the NASH Tunnel?. Livers 2024; 4(1): 138 doi: 10.3390/livers4010010
|
| 6 |
Tomasz Charytoniuk, Krzysztof Drygalski, Karolina Konstantynowicz-Nowicka, Klaudia Berk, Adrian Chabowski. Alternative treatment methods attenuate the development of NAFLD: A review of resveratrol molecular mechanisms and clinical trials. Nutrition 2017; 34: 108 doi: 10.1016/j.nut.2016.09.001
|
| 7 |
Farah Diab, Hawraa Zbeeb, Lama Zeaiter, Francesca Baldini, Aldo Pagano, Velia Minicozzi, Laura Vergani. Unraveling the metabolic activities of bioactive compounds on cellular models of hepatosteatosis and adipogenesis through docking analysis with PPARs. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-78374-7
|
| 8 |
Rohit A. Sinha, Brijesh K. Singh, Paul M. Yen. Direct effects of thyroid hormones on hepatic lipid metabolism. Nature Reviews Endocrinology 2018; 14(5): 259 doi: 10.1038/nrendo.2018.10
|
| 9 |
Francesca Baldini, Alice Bartolozzi, Martina Ardito, Adriana Voci, Piero Portincasa, Massimo Vassalli, Laura Vergani. Biomechanics of cultured hepatic cells during different steatogenic hits. Journal of the Mechanical Behavior of Biomedical Materials 2019; 97: 296 doi: 10.1016/j.jmbbm.2019.05.036
|
| 10 |
Elena Silvestri, Maria Coppola, Federica Cioffi, Fernando Goglia. Proteomic approaches for the study of tissue specific effects of 3,5,3′-triiodo-L-thyronine and 3,5-diiodo-L-thyronine in conditions of altered energy metabolism. Frontiers in Physiology 2014; 5 doi: 10.3389/fphys.2014.00491
|
| 11 |
Antonia Giacco, Giuseppe Petito, Elena Silvestri, Nicla Scopigno, Michela Vigliotti, Giovanna Mercurio, Pieter de Lange, Assunta Lombardi, Maria Moreno, Fernando Goglia, Antonia Lanni, Rosalba Senese, Federica Cioffi. Comparative effects of 3,5-diiodo-L-thyronine and 3,5,3’-triiodo-L-thyronine on mitochondrial damage and cGAS/STING-driven inflammation in liver of hypothyroid rats. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1432819
|
| 12 |
A. Baranova, D. Maltseva, A. Tonevitsky. Adipose may actively delay progression of NAFLD by releasing tumor‐suppressing, anti‐fibrotic miR‐122 into circulation. Obesity Reviews 2019; 20(1): 108 doi: 10.1111/obr.12765
|
| 13 |
Rajvi Gor, Nabeel A Siddiqui, Ransirini Wijeratne Fernando, Archana Sreekantan Nair, Janan Illango, Mushrin Malik, Pousette Hamid. Unraveling the Role of Hypothyroidism in Non-alcoholic Fatty Liver Disease Pathogenesis: Correlations, Conflicts, and the Current Stand. Cureus 2021; doi: 10.7759/cureus.14858
|